Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
197 participants
INTERVENTIONAL
2009-03-31
2010-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Model 4296 Left Ventricular (LV) Lead Study
NCT00927251
Model 4396 Left Ventricular (LV) Lead Chronic Performance Study
NCT01361685
Model 20066 Left Ventricular (LV) Lead Study
NCT01365234
Attain Model 4196 Left Ventricular (LV) Lead
NCT00271544
Model 4195 Left Ventricular (LV) Lead Chronic Performance Study
NCT00869921
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Model 4396 LV Lead
Non-randomized study.
Pacing Lead
implant and follow-up of study device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pacing Lead
implant and follow-up of study device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic Cardiac Rhythm and Heart Failure
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Derek Exner, MD
Role: PRINCIPAL_INVESTIGATOR
Foothills Hospital (University of Calgary)
Daniel Gras, MD
Role: PRINCIPAL_INVESTIGATOR
Nouvelles Cliniques Nantaises
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pasadena, California, United States
Sacramento, California, United States
Atlantis, Florida, United States
Atlanta, Georgia, United States
Hinsdale, Illinois, United States
Davenport, Iowa, United States
Kansas City, Kansas, United States
Lexington, Kentucky, United States
Baton Rouge, Louisiana, United States
Saint Louis Park, Minnesota, United States
Saint Paul, Minnesota, United States
Liverpool, New York, United States
New York, New York, United States
Durham, North Carolina, United States
Portland, Oregon, United States
York, Pennsylvania, United States
Nashville, Tennessee, United States
Austin, Texas, United States
Morgantown, West Virginia, United States
Bendigo, , Australia
Linz, , Austria
Calgary, Alberta, Canada
Vancouver, British Columbia, Canada
Newmarket, Ontario, Canada
Montreal, Quebec, Canada
Québec, Quebec, Canada
Aarhus, , Denmark
Nantes, , France
Toulouse, , France
Treviso, , Italy
Riyadh, , Saudi Arabia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
116
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.